跳至主要内容
临床试验/NL-OMON50476
NL-OMON50476已完成不适用

Assessment of Responsiveness to Treatment of the Experience Sampling Method (ESM) in Irritable Bowel Syndrome using linaclotide - ESM Linaclotide

niversiteit Maastricht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Diagnosis of IBS-C according to Rome IV criteria; negative colonoscopy in the
  • past 5 years prior to inclusion; age between 18 and 75 years; treatment in
  • primary care unsuccessful for 12 months; ability to understand, read and speak
  • the Dutch language; ability to understand how to utilize the MEASuRE app on a
  • smartphone.

排除标准

  • Appendectomy or cholecystectomy within 2 months or other abdominal surgeries
  • within 6 months before entry into the study; history of laxative abuse; current
  • use of drugs that could initiate constipation (e.g. narcotics), use of any
  • IBS-related drugs possibly causing constipation (e.g. tricyclic
  • antidepressants) are a reason for exclusion, unless usage is on a stable dose
  • for at least 30 days before inclusion and there is no plan to change the dose
  • during the study period.

研究者

相似试验